Novozymes A/S/DKr NSIS B
08:00
10:00
12:00
13:55
15:55
1D1W1MYTD1Y5YMAX
About Novozymes A/S
Novozymes A/S is a biotechnology company headquartered in Bagsværd, Denmark, specializing in the production and distribution of enzymes and microbial solutions. The company's core business spans multiple industries, including agriculture, bioenergy, food and beverages, and household care. Novozymes develops essential products such as enzymes for laundry detergents, animal feed additives, and biofuel production aids. Founded in 2000, it originated from a division of the pharmaceutical company Novo Nordisk. The company has a global presence, with significant operations in North America, Europe, and Asia. Novozymes is strategically positioned to capitalize on growing demand for sustainable solutions through its strong commitment to innovation and extensive expertise in biosolutions.
Ticker
DKr NSIS B
Sector
Primary listing
CSE
Employees
11,098
Headquarters
Lyngby, Denmark
Website
Novozymes A/S Metrics
BasicAdvanced
kr 167B
38.18
kr 9.34
0.75
kr 6.45
1.81%
Price and volume
Market cap
kr 167B
Beta
0.75
52-week high
kr 479.50
52-week low
kr 345.30
Average daily volume
737K
Dividend rate
kr 6.45
Financial strength
Current ratio
0.723
Quick ratio
0.434
Long term debt to equity
12.012
Total debt to equity
27.686
Dividend payout ratio (TTM)
69.00%
Interest coverage (TTM)
14.08%
Profitability
EBITDA (TTM)
11,481.742
Gross margin (TTM)
55.45%
Net profit margin (TTM)
14.04%
Operating margin (TTM)
23.13%
Effective tax rate (TTM)
21.50%
Revenue per employee (TTM)
kr 2,764,880
Management effectiveness
Return on assets (TTM)
3.81%
Return on equity (TTM)
5.30%
Valuation
Price to earnings (TTM)
38.176
Price to revenue (TTM)
5.359
Price to book
15.34
Price to tangible book (TTM)
-714.06
Price to free cash flow (TTM)
29.679
Free cash flow yield (TTM)
3.37%
Free cash flow per share (TTM)
12.015
Dividend yield (TTM)
1.81%
Growth
Revenue change (TTM)
8.45%
Earnings per share change (TTM)
86.57%
3-year revenue growth (CAGR)
20.94%
10-year revenue growth (CAGR)
8.29%
3-year earnings per share growth (CAGR)
-10.88%
10-year earnings per share growth (CAGR)
0.23%
3-year dividend per share growth (CAGR)
2.70%
10-year dividend per share growth (CAGR)
6.39%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Novozymes A/S stock?
Novozymes A/S (NSIS B) has a market cap of DKr167B as of March 15, 2026.
What is the P/E ratio for Novozymes A/S stock?
The price to earnings (P/E) ratio for Novozymes A/S (NSIS B) stock is 38.18 as of March 15, 2026.
Does Novozymes A/S stock pay dividends?
Yes, the Novozymes A/S (NSIS B) stock pays dividends to shareholders. As of March 15, 2026, the dividend rate is DKr6.45 and the yield is 1.81%. Novozymes A/S has a payout ratio of 69% on a trailing twelve-month basis.
When is the next Novozymes A/S dividend payment date?
The next Novozymes A/S (NSIS B) dividend payment is scheduled for March 26, 2026.
What is the beta indicator for Novozymes A/S?
Novozymes A/S (NSIS B) has a beta rating of 0.75. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.